Skip to content

Comparison of the Effectiveness of Radial Extracorporeal Shockwave Therapy Versus High Intensity Laser Therapy in Patients With Myofascial Pain Syndrome of Upper Trapezius Muscle

Comparison of the Effectiveness of Radial Extracorporeal Shockwave Therapy Versus High Intensity Laser Therapy in Patients With Myofascial Pain Syndrome of Upper Trapezius Muscle

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240207060929N1
Enrollment
69
Registered
2024-02-26
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial pain syndrome at Upper trapezius muscle. Other and unspecified soft tissue disorders, not elsewhere classified

Interventions

Intervention 1: Intervention group 1: Participants in the Shockwave group will receive 2,000 shocks, consisting of 1,000 shocks at 1.5 bars with a frequency of 15 Hz at trigger points, and 1,000 shock

Sponsors

Walailak university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 24 Years

Inclusion criteria

Inclusion criteria: A student aged between 18-24 years Diagnosed with Myofascial pain syndrome of the Upper trapezius muscle Duration of pain is equal to or more than 3 months Severity of pain during the day is equal to or more than 3 out of 10 (pain scale = 3/10)

Exclusion criteria

Exclusion criteria: Use of medication such as anti-coagulants, pain relievers, and anti-inflammatories History of cancer Current infection or wound in the area requiring treatment Patient with a pacemaker History of easy bleeding Pregnant Diagnosed by a physician with a mental disorder such as depression Vigorous exercise or physical activity Experienced trauma in the neck area affecting the function of the upper trapezius muscle, such as wounds, fractures, or whiplash injuries Currently undergoing treatment for pain in the upper trapezius muscle area

Design outcomes

Primary

MeasureTime frame
Range of motion of the neck. Timepoint: Before intervention and 1, 2, 3, 4 weeks after intervention. Method of measurement: Measurements will be conducted using a cervical range of motion device. The starting position will be seated in a chair. From this position, the degree of neck flexion, neck extension, lateral flexion of the neck, and neck rotation will be measured.;Neck function. Timepoint: Before intervention and 1, 2, 3, 4 weeks after intervention. Method of measurement: The Neck Disability Index (NDI) comprises 10 questions covering the following areas: Pain Intensity, Personal Care, Lifting, Reading, Headaches, Concentration, Work, Driving, Sleep, and Recreation. Each question offers six choices, with scores ranging from 0 to 5. A score of 0 indicates no pain or interference with activity, while a score of 5 signifies very severe pain or extreme disruption, to the point of being unable to perform the activity. The total possible score for the NDI assessment ranges from 0 to 50 points.;Frequency of pain. Timepoint: Before intervention and 1, 2, 3, 4 weeks after intervention. Method of measurement: A questionnaire will be utilized to investigate the frequency of pain.;Pain symptoms at upper trapezius muscle. Timepoint: Before intervention and 4 weeks after intervention. Method of measurement: Pain symptoms will be assessed using a Pressure Algometer, with participants indicating their level of pain on the Visual Analog Scale (VAS).;Muscle length of the Upper trapezius muscle. Timepoint: Before intervention and 1, 2, 3, 4 weeks after intervention. Method of measurement: Muscle length will be measured using tape measurement, with assessment points located between the Spinous process of C7 and the Distal end of the acromion process. This measurement will be taken during neck flexion combined with lateral flexion to the opposite side and rotation to the same side.

Countries

Thailand

Contacts

Public ContactSirinthip Pakdee

Walailak University

Sirinthip.pa@wu.ac.th+66 75 672 611

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026